Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Genet Mol Res ; 13(2): 2458-69, 2014 Apr 03.
Article in English | MEDLINE | ID: mdl-24782000

ABSTRACT

Bovine papillomaviruses (BPVs) are recognized as causal agents of benign and malignant tumors in cattle. Thirteen types of BPVs have already been described and classified into 3 distinct genera. Divergences in the nucleotide sequence of the L1 gene are used to identify new viral types through the employment of PCR assays with degenerated primers. In the present study, a method for identifying BPVs based on PCR-RFLP and DNA sequencing allowed the identification of a new putative Deltapapillomavirus, designated JN/3SP (JQ280500.1). The analysis of the L1 gene showed that this strain was most closely related to the BPVs -1, -2, -13 , and OaPV1 (71-73% genetic similarity). In this study, we describe the detection of this new putative Deltapapillomavirus type and verify its phylogenetic position within the genus.


Subject(s)
Cattle Diseases/virology , Deltapapillomavirus/genetics , Deltapapillomavirus/isolation & purification , Phylogeny , Amino Acid Sequence , Animals , Cattle , Cattle Diseases/genetics , Deltapapillomavirus/classification , Deltapapillomavirus/pathogenicity , Sequence Analysis, DNA
2.
ISRN Oncol ; 2013: 910849, 2013.
Article in English | MEDLINE | ID: mdl-24298391

ABSTRACT

THE MAJORITY OF MALIGNANT CELLS PRESENT GENETIC INSTABILITY WITH CHROMOSOME NUMBER CHANGES PLUS SEGMENTAL DEFECTS: these changes involve intact chromosomes and breakage-induced alterations. Some pathways of chromosomal instability have been proposed as random breakage, telomere fusion, and centromere fission. Chromosome alterations in tumor cells have been described in animal models and in vitro experiments. One important question is about possible discrepancies between animal models, in vitro studies, and the real events in cancer cells in vivo. Papillomaviruses are relevant agents in oncogenic processes related to action on host genome. Recently, many reports have discussed the presence of virus DNA in peripheral blood, in humans and in animals infected by papillomaviruses. The meaning of this event is of controversy: possible product of apoptosis occurring in cancer cells, metastasized cancer cells, or active DNA sequences circulating in bloodstream. This study compares chromosome aberrations detected in bovine cells, in peripheral blood cells, and in BPV lesion cells: the literature is poor in this type of study. Comparing chromosome aberrations described in the different cells, a common mechanism in their origin, can be suggested. Furthermore blood cells can be evaluated as an effective way of virus transmission.

3.
Biomed Res Int ; 2013: 270898, 2013.
Article in English | MEDLINE | ID: mdl-23865043

ABSTRACT

Bovine papillomavirus (BPV) is recognized as a causal agent of benign and malignant tumors in cattle. Thirteen types of BPV are currently characterized and classified into three distinct genera, associated with different pathological outcomes. The described BPV types as well as other putative ones have been demonstrated by molecular biology methods, mainly by the employment of degenerated PCR primers. Specifically, divergences in the nucleotide sequence of the L1 gene are useful for the identification and classification of new papillomavirus types. On the present work, a method based on the PCR-RFLP technique and DNA sequencing was evaluated as a screening tool, allowing for the detection of two relatively rare types of BPV in lesions samples from a six-year-old Holstein dairy cow, chronically affected with cutaneous papillomatosis. These findings point to the dissemination of BPVs with unclear pathogenic potential, since two relatively rare, new described BPV types, which were first characterized in Japan, were also detected in Brazil.


Subject(s)
Cattle Diseases/virology , Coinfection/veterinary , Deltapapillomavirus/genetics , Deltapapillomavirus/isolation & purification , Papillomavirus Infections/veterinary , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length/genetics , Animals , Biopsy , Brazil , Cattle , Cattle Diseases/genetics , Cattle Diseases/pathology , Coinfection/genetics , Coinfection/pathology , Coinfection/virology , Papillomavirus Infections/genetics , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Phylogeny , Warts/pathology , Warts/virology
4.
Toxicon ; 36(2): 391-403, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9620587

ABSTRACT

The systemic symptoms, tissue lesions and release of cytokines were analysed in four isogenic mouse strains with distinct haplotypes injected with various doses of Loxosceles intermedia spider venom. The estimated LD50 were 24.5 microg for C57Bl/6, 17.6 microg for BALB/c, 6.3 microg for C3H/HeJ and 4.6 microg for A/Sn mice. Prostration, acute cachexia, hypothermia, neurological disorders and hemoglobinuria were the signals preceding death. Accumulation of eosinophilic material inside the proximal and distal renal tubules and acute tubular necrosis were the most common histopathological findings. Death was prevented by previous treatment of venom with specific antivenom serum. The protein F35 purified from the whole venom retained the ability to induce the symptoms of the whole venom. The cytokines tumor necrosis factor (TNF), interleukins IL-6 and IL-10 and the radical nitric oxide were detected in serum at different levels after venom injection. These findings indicate that the state of shock produced in mice by whole endotoxin-free L. intermedia venom or by its purified fraction, protein F35, mimics the endotoxemic shock, that susceptibility to the systemic effects of the venom varies among mice of different haplotypes and that the pattern of in vivo cytokine release resembles that of endotoxemic shock.


Subject(s)
Cytokines/blood , Shock, Septic/pathology , Spider Venoms/toxicity , Animals , Antibodies, Monoclonal/administration & dosage , Antivenins/therapeutic use , Cyclooxygenase Inhibitors/therapeutic use , Enzyme-Linked Immunosorbent Assay , Indomethacin/therapeutic use , Lethal Dose 50 , Male , Mice , Mice, Inbred A , Mice, Inbred BALB C , Mice, Inbred C3H , Mice, Inbred C57BL , Neutralization Tests , Shock, Septic/physiopathology , Shock, Septic/prevention & control , Species Specificity , Spider Venoms/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL